Role Of Signal Regulatory Protein A In Arsenic Trioxide-Induced Promyelocytic Leukemia Cell Apoptosis

Chaoyun Pan,Dihan Zhu,Jianjiang Zhuo,Limin Li,Dong Wang,Chen-Yu Zhang,Yuan Liu,Ke Zen
DOI: https://doi.org/10.1038/srep23710
IF: 4.6
2016-01-01
Scientific Reports
Abstract:Signal regulatory protein a (SIRP alpha) has been shown to operate as a negative regulator in cancer cell survival. The mechanism underneath such function, however, remains poorly defined. In the present study, we demonstrate that overexpression of SIRP alpha in acute promyelocytic leukemia (APL) cells results in apoptosis possibly via inhibiting the beta-catenin signaling pathway and upregulating Foxo3a. Pharmacological activation of beta-catenin signal pathway attenuates apoptosis caused by SIRP alpha. Interestingly, we also find that the pro-apoptotic effect of SIRP alpha plays an important role in arsenic trioxide (ATO)-induced apoptosis in APL cells. ATO treatment induces the SIRP alpha protein expression in APL cells and abrogation of SIRP alpha induction by lentivirus-mediated SIRP alpha shRNA significantly reduces the ATO-induced apoptosis. Mechanistic study further shows that induction of SIRP alpha protein in APL cells by ATO is mediated through suppression of c-Myc, resulting in reduction of three SIRP alpha-targeting microRNAs: miR-17, miR-20a and miR-106a. In summary, our results demonstrate that SIRP alpha inhibits tumor cell survival and significantly contributes to ATO-induced APL cell apoptosis.
What problem does this paper attempt to address?